132 related articles for article (PubMed ID: 15163650)
1. Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones.
Steward J; Lever MS; Simpson AJ; Sefton AM; Brooks TJ
J Antimicrob Chemother; 2004 Jul; 54(1):95-9. PubMed ID: 15163650
[TBL] [Abstract][Full Text] [Related]
2. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
Piercy T; Steward J; Lever MS; Brooks TJ
J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941
[TBL] [Abstract][Full Text] [Related]
3. Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection.
Steward J; Piercy T; Lever MS; Nelson M; Simpson AJ; Brooks TJ
J Antimicrob Chemother; 2005 Apr; 55(4):523-7. PubMed ID: 15731198
[TBL] [Abstract][Full Text] [Related]
4. Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin.
Steward J; Piercy T; Lever MS; Simpson AJ; Brooks TJ
Int J Antimicrob Agents; 2006 May; 27(5):439-43. PubMed ID: 16621457
[TBL] [Abstract][Full Text] [Related]
5. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
[TBL] [Abstract][Full Text] [Related]
6. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic analysis of fluoroquinolones against Bacillus anthracis.
Kihira T; Sato J; Shibata T
J Infect Chemother; 2004 Apr; 10(2):97-100. PubMed ID: 15160302
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection.
Atkins HS; Spencer S; Brew SD; Laws TR; Thirlwall RE; MacMillan AP; Brooks TJ; Simpson AJ
Int J Antimicrob Agents; 2009 Nov; 34(5):471-3. PubMed ID: 19682862
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice.
Stearne LE; Vonk AG; Kullberg BJ; Gyssens IC
Antimicrob Agents Chemother; 2005 Sep; 49(9):3668-75. PubMed ID: 16127038
[TBL] [Abstract][Full Text] [Related]
10. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
[TBL] [Abstract][Full Text] [Related]
11. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.
Solomon R; Donnenfeld ED; Perry HD; Snyder RW; Nedrud C; Stein J; Bloom A
Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model.
Ambrose PG; Forrest A; Craig WA; Rubino CM; Bhavnani SM; Drusano GL; Heine HS
Antimicrob Agents Chemother; 2007 Dec; 51(12):4351-5. PubMed ID: 17875992
[TBL] [Abstract][Full Text] [Related]
13. The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.
Burka JM; Bower KS; Vanroekel RC; Stutzman RD; Kuzmowych CP; Howard RS
Am J Ophthalmol; 2005 Jul; 140(1):83-7. PubMed ID: 15953577
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.
Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ
Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886
[TBL] [Abstract][Full Text] [Related]
15. Post-exposure therapy of inhalational anthrax in the common marmoset.
Nelson M; Stagg AJ; Stevens DJ; Brown MA; Pearce PC; Simpson AJ; Lever MS
Int J Antimicrob Agents; 2011 Jul; 38(1):60-4. PubMed ID: 21530184
[TBL] [Abstract][Full Text] [Related]
16. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.
Deramo VA; Lai JC; Fastenberg DM; Udell IJ
Am J Ophthalmol; 2006 Nov; 142(5):721-5. PubMed ID: 16989762
[TBL] [Abstract][Full Text] [Related]
17. Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries.
Huang HC; Shieh CC; Yu WL; Cheng KC; Chen CC; Chang ST; Chuang YC
Respirology; 2008 Jan; 13(1):47-52. PubMed ID: 18197910
[TBL] [Abstract][Full Text] [Related]
18. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
Vallet CM; Marquez B; Ngabirano E; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
[TBL] [Abstract][Full Text] [Related]
19. Anthrax-protective effects of yeast beta 1,3 glucans.
Kournikakis B; Mandeville R; Brousseau P; Ostroff G
MedGenMed; 2003 Mar; 5(1):1. PubMed ID: 12827062
[TBL] [Abstract][Full Text] [Related]
20. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.
Ong-Tone L
J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
